Than Powell

About

Proven track record of building and scaling businesses and teams as public company CEO, start-up Co-Founder and CEO, and Executive leader in big pharma and biotech. Successful exits to Private Equity, public funding through Institutional Investors, and multiple strategic partnerships. Most recently served as Interim CEO and Chief Business Officer of Longeveron, a public clinical-stage biotech. Led company through public funding round and ultimately Institutional Fund investment to support operations through pivotal study read-out. Continue to advise on business development and strategic partnerships. Additional career highlights:• Vice President, Corporate Development and Strategy at Surescripts, LLC through a successful M&A process resulting in an acquisition by TPG at 28x EBITDA multiple. • CEO & Co-founder of Epulate, LLC a venture-backed health tech start-up focused on improving the way transplant patients are matched to donated organs by leveraging advanced analytics, machine learning, and emerging science in transplant immunology. • 20+ years in the pharmaceutical and biotech industry at Eli Lilly & Co and GSK leading business units, pipeline development/clinical trial strate

Experience

Education